课题基金 / 基金详情

Neurovascular Dysfunction, BBB Disruption and Oxidative Stress in Ischemic Brain

Neurovascular Dysfunction, BBB Disruption and Oxidative Stress in Ischemic Brain
缺血性脑中的神经血管功能障碍、血脑屏障破坏和氧化应激
批准号:
7382855
负责人:
PAK H CHAN
金额:
$51.09万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-01 至 2012-06-30

项目摘要

项目成果

PAK H CHAN的其他基金

相关文献

中文摘要
翻译
脑缺血再灌注过程中产生的氧化应激是导致血脑损伤的重要事件
英文摘要
Oxidative stress generated during cerebral ischemia and reperfusion is a critical event leading to bloodbrain barrier (BBB) disruption, with secondary vasogenic edema and hemorrhagic transformation of infarcted brain tissue, restricting the benefit of tissue reperfusion with thrombolytic agents. We have demonstrated that mild cerebral ischemia (30 minutes) in mice deficient in manganese-superoxide dismutase (SOD2-/+) caused delayed (>24 hours) BBB breakdown associated with activation of matrix metalloproteinase (MMP), inflammation, and high brain hemorrhage rates. Our preliminary studies have further shown that overexpression of endothelial NADPH oxidase is associated with the formation of hemorrhagic transformation and intracerebral hemorrhage (ICH) in the SOD2 -/+ mice, and that inhibition of NADPH oxidase significantly reduces ICH and infarct volume. We now hypothesize that activation of endothelial NADPH oxidase and expression of extracellular signal-regulated kinase (ERK) 1/2 signaling cause neurovascular dysfunction, BBB disruption, and endothelial cell death by activation of MMP-9. Our aim is to test this hypothesis using this newly developed model of SOD2-/+ mice with delayed BBB disruption. We believe these are novel studies that will provide insights into therapeutic opportunities to minimize oxidative stress-associated hemorrhagic transformation in patients who suffer acute ischemic stroke.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Transgenic Animal Core
  • 批准号:
    7382861
  • 项目类别:
  • 资助金额:
    $26.5万
  • 财政年份:
    2007
  • 负责人:
    PAK H CHAN
  • 依托单位:
Administrative Core
  • 批准号:
    7382863
  • 项目类别:
  • 资助金额:
    $13.98万
  • 财政年份:
    2007
  • 负责人:
    PAK H CHAN
  • 依托单位:
Core--Transgenic animal
  • 批准号:
    6809074
  • 项目类别:
  • 资助金额:
    $19.41万
  • 财政年份:
    2004
  • 负责人:
    PAK H CHAN
  • 依托单位:
Endothelial vascular injury
  • 批准号:
    6809066
  • 项目类别:
  • 资助金额:
    $21.01万
  • 财政年份:
    2004
  • 负责人:
    PAK H CHAN
  • 依托单位: